SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001587221-21-000018
Filing Date
2021-05-12
Accepted
2021-05-12 16:24:15
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zsan-20210331.htm   iXBRL 10-Q 1386663
2 EX-31.1 exhibit311q1-202110q.htm EX-31.1 9276
3 EX-31.2 exhibit312q1-202110q.htm EX-31.2 9194
4 EX-32.1 exhibit321q1-202110q.htm EX-32.1 7945
  Complete submission text file 0001587221-21-000018.txt   5984699

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20210331.xsd EX-101.SCH 52035
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zsan-20210331_cal.xml EX-101.CAL 87680
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zsan-20210331_def.xml EX-101.DEF 225013
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20210331_lab.xml EX-101.LAB 542783
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20210331_pre.xml EX-101.PRE 344877
10 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20210331_htm.xml XML 865175
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 21915463
SIC: 2834 Pharmaceutical Preparations